BVT Put 175 Consumer Discr. Selec.../ DE000VD4BJA0 /
6/5/2024 8:03:27 PM | Chg.-0.039 | Bid9:59:56 PM | Ask9:59:56 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.152EUR | -20.42% | - Bid Size: - |
- Ask Size: - |
- | 175.00 USD | 6/21/2024 | Put |
GlobeNewswire
10:10 PM
EXAI STOCKHOLDERS – Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in...
Newsfile Corp
10:10 PM
ROSEN, A LEADING LAW FIRM, Encourages Northern Genesis Acquisition Corp. n/k/a The Lion Electric Com...
GlobeNewswire
10:10 PM
NN, Inc. Executive Management to Present at the Sidoti June Small Cap Investor Conference
GlobeNewswire
10:09 PM
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
GlobeNewswire
10:06 PM
GDRX STOCKHOLDERS – Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in...
GlobeNewswire
10:05 PM
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
10:05 PM
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Co...
GlobeNewswire
10:05 PM
PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly...
GlobeNewswire
10:05 PM
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®
GlobeNewswire
10:05 PM
CPI Aerostructures Receives $1.3 Million Follow-on Orders for Welded Assemblies
GlobeNewswire
10:05 PM
QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of it...
GlobeNewswire
10:01 PM
Bruster's Real Ice Cream Donates Over 3,000 Sets of Pajamas to Foster Care Youth National Nonprofit,...
GlobeNewswire
10:01 PM
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
10:01 PM
Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Dem...
GlobeNewswire
10:00 PM
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)